Nan Wu

4.9k total citations · 2 hit papers
92 papers, 3.3k citations indexed

About

Nan Wu is a scholar working on Molecular Biology, Cancer Research and Pathology and Forensic Medicine. According to data from OpenAlex, Nan Wu has authored 92 papers receiving a total of 3.3k indexed citations (citations by other indexed papers that have themselves been cited), including 57 papers in Molecular Biology, 35 papers in Cancer Research and 19 papers in Pathology and Forensic Medicine. Recurrent topics in Nan Wu's work include Circular RNAs in diseases (29 papers), MicroRNA in disease regulation (25 papers) and Cardiac Ischemia and Reperfusion (16 papers). Nan Wu is often cited by papers focused on Circular RNAs in diseases (29 papers), MicroRNA in disease regulation (25 papers) and Cardiac Ischemia and Reperfusion (16 papers). Nan Wu collaborates with scholars based in China, Canada and United States. Nan Wu's co-authors include Burton B. Yang, William W. Du, Ling Fang, Faryal Mehwish Awan, Weining Yang, Dalin Jia, Zhenguo Yang, Sema Mısır, Pengyu Jia and Jian Ma and has published in prestigious journals such as Nature Communications, Circulation Research and Analytical Chemistry.

In The Last Decade

Nan Wu

89 papers receiving 3.3k citations

Hit Papers

Induction of tumor apoptosis through a circular RNA enhan... 2016 2026 2019 2022 2016 2022 100 200 300 400 500

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nan Wu China 29 2.6k 1.9k 282 198 175 92 3.3k
Qing Liu China 33 1.6k 0.6× 1.4k 0.7× 230 0.8× 177 0.9× 107 0.6× 128 2.9k
Wei Zhao China 33 2.2k 0.9× 1.6k 0.9× 120 0.4× 201 1.0× 88 0.5× 143 3.2k
Murugavel Ponnusamy China 37 2.7k 1.1× 1.4k 0.7× 312 1.1× 395 2.0× 335 1.9× 62 4.4k
Mei Liu China 32 2.0k 0.8× 931 0.5× 137 0.5× 369 1.9× 100 0.6× 108 3.2k
Wenzhi Guo China 30 1.6k 0.6× 836 0.4× 128 0.5× 345 1.7× 104 0.6× 213 3.1k
Caiyu Chen China 27 1.5k 0.6× 838 0.4× 138 0.5× 163 0.8× 383 2.2× 72 2.5k
Song Wu China 26 1.2k 0.5× 567 0.3× 229 0.8× 161 0.8× 77 0.4× 137 2.2k
Xin He China 31 1.6k 0.6× 698 0.4× 179 0.6× 337 1.7× 60 0.3× 103 3.1k

Countries citing papers authored by Nan Wu

Since Specialization
Citations

This map shows the geographic impact of Nan Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nan Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nan Wu more than expected).

Fields of papers citing papers by Nan Wu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nan Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nan Wu. The network helps show where Nan Wu may publish in the future.

Co-authorship network of co-authors of Nan Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Nan Wu. A scholar is included among the top collaborators of Nan Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nan Wu. Nan Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Wang, Ruixuan, et al.. (2025). Super-enhancers and Mef2c: Novel regulators of cardiac hypertrophy via the Hey2/Notch/p38 signaling pathway. European Journal of Pharmacology. 1002. 177771–177771.
3.
Zhao, Wenfeng, Xinqi Huang, Rui Li, et al.. (2025). Dysfunctional circular RNA network in major depressive disorder: dissecting the cell identity and potential clinical applications. Molecular Psychiatry. 31(1). 498–513.
4.
Du, William W., Weining Yang, Xiangmin Li, et al.. (2024). The Circular RNA circSKA3 Binds Integrin β1 to Induce Invadopodium Formation Enhancing Breast Cancer Invasion. Molecular Therapy. 33(1). 416–416. 2 indexed citations
5.
Ji, Jun, Tao Hu, Tong Lin, et al.. (2023). Down‐regulation of OIP5‐AS1 inhibits obesity‐induced myocardial pyroptosis and miR‐22/NLRP3 inflammasome axis. Immunity Inflammation and Disease. 11(10). e1066–e1066. 5 indexed citations
6.
Wu, Nan, et al.. (2022). CircRNA perspective: new strategies for RNA therapy. Trends in Molecular Medicine. 28(4). 343–344. 25 indexed citations
7.
Zhang, Xiaowen, Nan Wu, & Jin Wang. (2021). Hsa-circ_0058106 induces EMT and metastasis in laryngeal cancer via sponging miR-153 and inducing Twist1 nuclear translocation. Cellular Oncology. 44(6). 1373–1386. 6 indexed citations
8.
Qi, Bin, Xiaowen Zhang, Hang Yu, et al.. (2021). Brazilin prevents against myocardial ischemia-reperfusion injury through the modulation of Nrf2 via the PKC signaling pathway. Annals of Translational Medicine. 9(4). 312–312. 12 indexed citations
9.
Jia, Pengyu, Nan Wu, Huimin Yang, et al.. (2021). Different roles of BAG3 in cardiac physiological hypertrophy and pathological remodeling. Translational research. 233. 47–61. 9 indexed citations
10.
Chen, Yuqiong, Li Su, Yuxuan Guo, et al.. (2020). Astaxanthin Attenuates Hypertensive Vascular Remodeling by Protecting Vascular Smooth Muscle Cells from Oxidative Stress-Induced Mitochondrial Dysfunction. Oxidative Medicine and Cellular Longevity. 2020. 1–19. 79 indexed citations
11.
Wu, Nan, Jindong Xu, William W. Du, et al.. (2020). YAP Circular RNA, circYap, Attenuates Cardiac Fibrosis via Binding with Tropomyosin-4 and Gamma-Actin Decreasing Actin Polymerization. Molecular Therapy. 29(3). 1138–1150. 78 indexed citations
12.
Zhuang, Juan, Fashui Hong, Chuankun Zhu, et al.. (2020). BDE-47 induced apoptosis in zebrafish embryos through mitochondrial ROS-mediated JNK signaling. Chemosphere. 258. 127385–127385. 53 indexed citations
13.
Yang, Hui-Min, Xin Xin, Hang Yu, et al.. (2020). <p>microRNA Expression Profiles in Myocardium of High-Fat Diet-Induced Obesity Rat</p>. Diabetes Metabolic Syndrome and Obesity. Volume 13. 1147–1159. 12 indexed citations
15.
Fang, Ling, William W. Du, Juanjuan Lyu, et al.. (2018). Enhanced breast cancer progression by mutant p53 is inhibited by the circular RNA circ-Ccnb1. Cell Death and Differentiation. 25(12). 2195–2208. 110 indexed citations
16.
Du, William W., Ling Fang, Weining Yang, et al.. (2016). Induction of tumor apoptosis through a circular RNA enhancing Foxo3 activity. Cell Death and Differentiation. 24(2). 357–370. 575 indexed citations breakdown →
17.
Wu, Nan, Xiaowen Zhang, Pengyu Jia, & Dalin Jia. (2015). Hypercholesterolemia aggravates myocardial ischemia reperfusion injury via activating endoplasmic reticulum stress-mediated apoptosis. Experimental and Molecular Pathology. 99(3). 449–454. 26 indexed citations
18.
Wu, Nan, Xiaowen Zhang, Pengyu Jia, & Dalin Jia. (2015). WITHDRAWN: Hypercholesterolemia aggravates myocardial ischemia reperfusion injury via activating endoplasmic reticulum stress-mediated apoptosis. Experimental and Molecular Pathology. 1 indexed citations
20.
Liu, Feng, Zhida Liu, Nan Wu, et al.. (2013). In vitro interactions between rat bone marrow-derived endothelial progenitor cells and hepatic stellate cells. In Vitro Cellular & Developmental Biology - Animal. 49(7). 537–547. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026